Related Experiment Video
Updated: Sep 6, 2025
04:57
Author Spotlight: Minimally Invasive Ultrasound-Guided Acupotomy in Knee Osteoarthritis Treatment
Published on: April 26, 2024
682
Genicular Artery Embolization for Primary Knee Osteoarthritis.
Ravi Tyagi1, S Samaduddin Ahmed2, Yilun Koethe3
1University of Illinois College of Medicine at Chicago, Chicago, Illinois.
Seminars in Interventional Radiology
|July 5, 2022
Summary
Genicular artery embolization (GAE) offers sustained pain relief for knee osteoarthritis (OA). This novel treatment shows significant improvement in patient-reported outcomes for mild to moderate cases.
Area of Science:
- Interventional Radiology
- Orthopedics
- Pain Management
Background:
- Knee osteoarthritis (OA) is a prevalent degenerative joint disease causing significant pain and disability.
- Existing OA treatments have limitations in efficacy and safety.
- Genicular artery embolization (GAE) is an emerging minimally invasive treatment targeting OA-related inflammation.
Purpose of the Study:
- To evaluate the efficacy and safety of genicular artery embolization (GAE) for knee osteoarthritis (OA).
- To assess the impact of GAE on pain and functional outcomes in OA patients.
Main Methods:
- Selective embolization of genicular arteries using microspheres.
- Targeting abnormal synovial hyperemia to reduce inflammation.
- Assessment of patient outcomes using WOMAC and VAS scores.
Main Results:
- GAE demonstrated sustained 6-month improvement in WOMAC and VAS scores.
- 80-85% of patients with mild to moderate OA experienced significant benefits.
- Reduction in abnormal synovial hyperemia observed post-embolization.
Conclusions:
- Genicular artery embolization (GAE) is a promising treatment for knee osteoarthritis (OA).
- GAE provides sustained pain relief and functional improvement.
- Further research is needed to compare GAE with placebo and standard therapies.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
28
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
28
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
250
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
250
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
223
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
01:30Peripheral Artery Disease I: Introduction
30
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
30